nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezetimibe—ABCC3—Methotrexate—psoriatic arthritis	0.127	0.157	CbGbCtD
Ezetimibe—ABCC2—Dexamethasone—psoriatic arthritis	0.0716	0.0886	CbGbCtD
Ezetimibe—SLCO1B1—Methotrexate—psoriatic arthritis	0.0655	0.081	CbGbCtD
Ezetimibe—ABCG2—Dexamethasone—psoriatic arthritis	0.0648	0.0801	CbGbCtD
Ezetimibe—ABCB1—Methylprednisolone—psoriatic arthritis	0.0618	0.0764	CbGbCtD
Ezetimibe—ABCC2—Methotrexate—psoriatic arthritis	0.0576	0.0712	CbGbCtD
Ezetimibe—ABCG2—Methotrexate—psoriatic arthritis	0.0521	0.0644	CbGbCtD
Ezetimibe—ABCB1—Betamethasone—psoriatic arthritis	0.0402	0.0497	CbGbCtD
Ezetimibe—ABCB1—Prednisolone—psoriatic arthritis	0.0396	0.049	CbGbCtD
Ezetimibe—ABCB1—Prednisone—psoriatic arthritis	0.0374	0.0463	CbGbCtD
Ezetimibe—CYP3A4—Methylprednisolone—psoriatic arthritis	0.037	0.0458	CbGbCtD
Ezetimibe—CYP3A4—Triamcinolone—psoriatic arthritis	0.028	0.0347	CbGbCtD
Ezetimibe—CYP3A4—Betamethasone—psoriatic arthritis	0.0241	0.0298	CbGbCtD
Ezetimibe—CYP3A4—Prednisolone—psoriatic arthritis	0.0237	0.0294	CbGbCtD
Ezetimibe—ABCB1—Dexamethasone—psoriatic arthritis	0.0234	0.0289	CbGbCtD
Ezetimibe—CYP3A4—Prednisone—psoriatic arthritis	0.0224	0.0277	CbGbCtD
Ezetimibe—ABCB1—Methotrexate—psoriatic arthritis	0.0188	0.0232	CbGbCtD
Ezetimibe—CYP3A4—Dexamethasone—psoriatic arthritis	0.014	0.0173	CbGbCtD
Ezetimibe—Neuropathy peripheral—Prednisone—psoriatic arthritis	0.000491	0.00256	CcSEcCtD
Ezetimibe—Breast disorder—Methotrexate—psoriatic arthritis	0.000491	0.00256	CcSEcCtD
Ezetimibe—Malaise—Prednisolone—psoriatic arthritis	0.000486	0.00254	CcSEcCtD
Ezetimibe—Back pain—Triamcinolone—psoriatic arthritis	0.000479	0.0025	CcSEcCtD
Ezetimibe—Angiopathy—Dexamethasone—psoriatic arthritis	0.000468	0.00245	CcSEcCtD
Ezetimibe—Angiopathy—Betamethasone—psoriatic arthritis	0.000468	0.00245	CcSEcCtD
Ezetimibe—Hypertension—Prednisolone—psoriatic arthritis	0.000465	0.00243	CcSEcCtD
Ezetimibe—Eosinophilia—Methotrexate—psoriatic arthritis	0.000465	0.00243	CcSEcCtD
Ezetimibe—Pancreatitis—Methotrexate—psoriatic arthritis	0.00046	0.0024	CcSEcCtD
Ezetimibe—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.00046	0.0024	CcSEcCtD
Ezetimibe—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.000459	0.0024	CcSEcCtD
Ezetimibe—Alopecia—Betamethasone—psoriatic arthritis	0.000456	0.00238	CcSEcCtD
Ezetimibe—Alopecia—Dexamethasone—psoriatic arthritis	0.000456	0.00238	CcSEcCtD
Ezetimibe—Discomfort—Prednisolone—psoriatic arthritis	0.000453	0.00237	CcSEcCtD
Ezetimibe—Angioedema—Triamcinolone—psoriatic arthritis	0.000453	0.00236	CcSEcCtD
Ezetimibe—Angioedema—Methylprednisolone—psoriatic arthritis	0.000452	0.00236	CcSEcCtD
Ezetimibe—Erythema—Betamethasone—psoriatic arthritis	0.000449	0.00235	CcSEcCtD
Ezetimibe—Erythema—Dexamethasone—psoriatic arthritis	0.000449	0.00235	CcSEcCtD
Ezetimibe—Malaise—Triamcinolone—psoriatic arthritis	0.000447	0.00233	CcSEcCtD
Ezetimibe—Malaise—Methylprednisolone—psoriatic arthritis	0.000446	0.00233	CcSEcCtD
Ezetimibe—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000442	0.00231	CcSEcCtD
Ezetimibe—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00044	0.0023	CcSEcCtD
Ezetimibe—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.000436	0.00228	CcSEcCtD
Ezetimibe—Erectile dysfunction—Methotrexate—psoriatic arthritis	0.000432	0.00226	CcSEcCtD
Ezetimibe—Cough—Triamcinolone—psoriatic arthritis	0.000432	0.00226	CcSEcCtD
Ezetimibe—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.000429	0.00224	CcSEcCtD
Ezetimibe—Hypertension—Triamcinolone—psoriatic arthritis	0.000428	0.00223	CcSEcCtD
Ezetimibe—Hypertension—Methylprednisolone—psoriatic arthritis	0.000427	0.00223	CcSEcCtD
Ezetimibe—Myalgia—Triamcinolone—psoriatic arthritis	0.000422	0.0022	CcSEcCtD
Ezetimibe—Myalgia—Methylprednisolone—psoriatic arthritis	0.000421	0.0022	CcSEcCtD
Ezetimibe—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000421	0.0022	CcSEcCtD
Ezetimibe—Infestation NOS—Methotrexate—psoriatic arthritis	0.000419	0.00219	CcSEcCtD
Ezetimibe—Infestation—Methotrexate—psoriatic arthritis	0.000419	0.00219	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000418	0.00218	CcSEcCtD
Ezetimibe—Flushing—Prednisone—psoriatic arthritis	0.000417	0.00218	CcSEcCtD
Ezetimibe—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000417	0.00218	CcSEcCtD
Ezetimibe—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000417	0.00218	CcSEcCtD
Ezetimibe—Discomfort—Triamcinolone—psoriatic arthritis	0.000417	0.00218	CcSEcCtD
Ezetimibe—Discomfort—Methylprednisolone—psoriatic arthritis	0.000416	0.00217	CcSEcCtD
Ezetimibe—Dry mouth—Triamcinolone—psoriatic arthritis	0.000412	0.00215	CcSEcCtD
Ezetimibe—Angioedema—Betamethasone—psoriatic arthritis	0.000411	0.00215	CcSEcCtD
Ezetimibe—Angioedema—Dexamethasone—psoriatic arthritis	0.000411	0.00215	CcSEcCtD
Ezetimibe—Angiopathy—Prednisone—psoriatic arthritis	0.000408	0.00213	CcSEcCtD
Ezetimibe—Confusional state—Methylprednisolone—psoriatic arthritis	0.000407	0.00212	CcSEcCtD
Ezetimibe—Immune system disorder—Prednisone—psoriatic arthritis	0.000406	0.00212	CcSEcCtD
Ezetimibe—Malaise—Betamethasone—psoriatic arthritis	0.000405	0.00212	CcSEcCtD
Ezetimibe—Malaise—Dexamethasone—psoriatic arthritis	0.000405	0.00212	CcSEcCtD
Ezetimibe—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000404	0.00211	CcSEcCtD
Ezetimibe—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000403	0.00211	CcSEcCtD
Ezetimibe—Infection—Triamcinolone—psoriatic arthritis	0.000402	0.0021	CcSEcCtD
Ezetimibe—Infection—Methylprednisolone—psoriatic arthritis	0.000401	0.00209	CcSEcCtD
Ezetimibe—Insomnia—Prednisolone—psoriatic arthritis	0.000398	0.00208	CcSEcCtD
Ezetimibe—Alopecia—Prednisone—psoriatic arthritis	0.000397	0.00208	CcSEcCtD
Ezetimibe—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000396	0.00207	CcSEcCtD
Ezetimibe—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000396	0.00207	CcSEcCtD
Ezetimibe—Paraesthesia—Prednisolone—psoriatic arthritis	0.000395	0.00206	CcSEcCtD
Ezetimibe—Mental disorder—Prednisone—psoriatic arthritis	0.000394	0.00206	CcSEcCtD
Ezetimibe—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000392	0.00205	CcSEcCtD
Ezetimibe—Erythema—Prednisone—psoriatic arthritis	0.000391	0.00204	CcSEcCtD
Ezetimibe—Malnutrition—Prednisone—psoriatic arthritis	0.000391	0.00204	CcSEcCtD
Ezetimibe—Hypertension—Dexamethasone—psoriatic arthritis	0.000388	0.00203	CcSEcCtD
Ezetimibe—Hypertension—Betamethasone—psoriatic arthritis	0.000388	0.00203	CcSEcCtD
Ezetimibe—Myalgia—Betamethasone—psoriatic arthritis	0.000383	0.002	CcSEcCtD
Ezetimibe—Myalgia—Dexamethasone—psoriatic arthritis	0.000383	0.002	CcSEcCtD
Ezetimibe—Discomfort—Betamethasone—psoriatic arthritis	0.000378	0.00197	CcSEcCtD
Ezetimibe—Discomfort—Dexamethasone—psoriatic arthritis	0.000378	0.00197	CcSEcCtD
Ezetimibe—Pain—Prednisolone—psoriatic arthritis	0.000376	0.00196	CcSEcCtD
Ezetimibe—Hepatitis—Methotrexate—psoriatic arthritis	0.000376	0.00196	CcSEcCtD
Ezetimibe—Pharyngitis—Methotrexate—psoriatic arthritis	0.000373	0.00195	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000368	0.00192	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000368	0.00192	CcSEcCtD
Ezetimibe—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000367	0.00192	CcSEcCtD
Ezetimibe—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000367	0.00192	CcSEcCtD
Ezetimibe—Insomnia—Triamcinolone—psoriatic arthritis	0.000366	0.00191	CcSEcCtD
Ezetimibe—Insomnia—Methylprednisolone—psoriatic arthritis	0.000365	0.00191	CcSEcCtD
Ezetimibe—Infection—Dexamethasone—psoriatic arthritis	0.000364	0.0019	CcSEcCtD
Ezetimibe—Infection—Betamethasone—psoriatic arthritis	0.000364	0.0019	CcSEcCtD
Ezetimibe—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000363	0.0019	CcSEcCtD
Ezetimibe—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000363	0.0019	CcSEcCtD
Ezetimibe—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000362	0.00189	CcSEcCtD
Ezetimibe—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000362	0.00189	CcSEcCtD
Ezetimibe—Anaemia—Prednisone—psoriatic arthritis	0.000362	0.00189	CcSEcCtD
Ezetimibe—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00036	0.00188	CcSEcCtD
Ezetimibe—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00036	0.00188	CcSEcCtD
Ezetimibe—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00036	0.00188	CcSEcCtD
Ezetimibe—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000359	0.00188	CcSEcCtD
Ezetimibe—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000359	0.00188	CcSEcCtD
Ezetimibe—Angioedema—Prednisone—psoriatic arthritis	0.000358	0.00187	CcSEcCtD
Ezetimibe—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000356	0.00186	CcSEcCtD
Ezetimibe—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000355	0.00186	CcSEcCtD
Ezetimibe—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000355	0.00185	CcSEcCtD
Ezetimibe—Malaise—Prednisone—psoriatic arthritis	0.000353	0.00184	CcSEcCtD
Ezetimibe—Urticaria—Prednisolone—psoriatic arthritis	0.000349	0.00182	CcSEcCtD
Ezetimibe—Fatigue—Triamcinolone—psoriatic arthritis	0.000349	0.00182	CcSEcCtD
Ezetimibe—Fatigue—Methylprednisolone—psoriatic arthritis	0.000348	0.00182	CcSEcCtD
Ezetimibe—Pain—Triamcinolone—psoriatic arthritis	0.000346	0.00181	CcSEcCtD
Ezetimibe—Angiopathy—Methotrexate—psoriatic arthritis	0.000341	0.00178	CcSEcCtD
Ezetimibe—Immune system disorder—Methotrexate—psoriatic arthritis	0.000339	0.00177	CcSEcCtD
Ezetimibe—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000339	0.00177	CcSEcCtD
Ezetimibe—Hypertension—Prednisone—psoriatic arthritis	0.000338	0.00177	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000334	0.00175	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000334	0.00175	CcSEcCtD
Ezetimibe—Myalgia—Prednisone—psoriatic arthritis	0.000333	0.00174	CcSEcCtD
Ezetimibe—Arthralgia—Prednisone—psoriatic arthritis	0.000333	0.00174	CcSEcCtD
Ezetimibe—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000333	0.00174	CcSEcCtD
Ezetimibe—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000332	0.00174	CcSEcCtD
Ezetimibe—Alopecia—Methotrexate—psoriatic arthritis	0.000332	0.00173	CcSEcCtD
Ezetimibe—Insomnia—Dexamethasone—psoriatic arthritis	0.000332	0.00173	CcSEcCtD
Ezetimibe—Insomnia—Betamethasone—psoriatic arthritis	0.000332	0.00173	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000331	0.00173	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00033	0.00172	CcSEcCtD
Ezetimibe—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000329	0.00172	CcSEcCtD
Ezetimibe—Paraesthesia—Betamethasone—psoriatic arthritis	0.000329	0.00172	CcSEcCtD
Ezetimibe—Discomfort—Prednisone—psoriatic arthritis	0.000329	0.00172	CcSEcCtD
Ezetimibe—Mental disorder—Methotrexate—psoriatic arthritis	0.000329	0.00172	CcSEcCtD
Ezetimibe—Erythema—Methotrexate—psoriatic arthritis	0.000327	0.00171	CcSEcCtD
Ezetimibe—Malnutrition—Methotrexate—psoriatic arthritis	0.000327	0.00171	CcSEcCtD
Ezetimibe—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000324	0.00169	CcSEcCtD
Ezetimibe—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000323	0.00169	CcSEcCtD
Ezetimibe—Dyspepsia—Betamethasone—psoriatic arthritis	0.000323	0.00169	CcSEcCtD
Ezetimibe—Urticaria—Triamcinolone—psoriatic arthritis	0.000321	0.00168	CcSEcCtD
Ezetimibe—Urticaria—Methylprednisolone—psoriatic arthritis	0.00032	0.00167	CcSEcCtD
Ezetimibe—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00032	0.00167	CcSEcCtD
Ezetimibe—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000319	0.00167	CcSEcCtD
Ezetimibe—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000319	0.00167	CcSEcCtD
Ezetimibe—Decreased appetite—Betamethasone—psoriatic arthritis	0.000319	0.00167	CcSEcCtD
Ezetimibe—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000319	0.00167	CcSEcCtD
Ezetimibe—Infection—Prednisone—psoriatic arthritis	0.000317	0.00166	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000317	0.00165	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000317	0.00165	CcSEcCtD
Ezetimibe—Back pain—Methotrexate—psoriatic arthritis	0.000316	0.00165	CcSEcCtD
Ezetimibe—Fatigue—Betamethasone—psoriatic arthritis	0.000316	0.00165	CcSEcCtD
Ezetimibe—Fatigue—Dexamethasone—psoriatic arthritis	0.000316	0.00165	CcSEcCtD
Ezetimibe—Pain—Dexamethasone—psoriatic arthritis	0.000314	0.00164	CcSEcCtD
Ezetimibe—Pain—Betamethasone—psoriatic arthritis	0.000314	0.00164	CcSEcCtD
Ezetimibe—Nervous system disorder—Prednisone—psoriatic arthritis	0.000313	0.00164	CcSEcCtD
Ezetimibe—Skin disorder—Prednisone—psoriatic arthritis	0.00031	0.00162	CcSEcCtD
Ezetimibe—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000304	0.00159	CcSEcCtD
Ezetimibe—Anaemia—Methotrexate—psoriatic arthritis	0.000302	0.00158	CcSEcCtD
Ezetimibe—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000302	0.00158	CcSEcCtD
Ezetimibe—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000302	0.00158	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.0003	0.00157	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.0003	0.00157	CcSEcCtD
Ezetimibe—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000298	0.00156	CcSEcCtD
Ezetimibe—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000297	0.00155	CcSEcCtD
Ezetimibe—Malaise—Methotrexate—psoriatic arthritis	0.000295	0.00154	CcSEcCtD
Ezetimibe—Urticaria—Dexamethasone—psoriatic arthritis	0.000291	0.00152	CcSEcCtD
Ezetimibe—Urticaria—Betamethasone—psoriatic arthritis	0.000291	0.00152	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000291	0.00152	CcSEcCtD
Ezetimibe—Dizziness—Prednisolone—psoriatic arthritis	0.000291	0.00152	CcSEcCtD
Ezetimibe—Asthenia—Triamcinolone—psoriatic arthritis	0.00029	0.00151	CcSEcCtD
Ezetimibe—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00029	0.00151	CcSEcCtD
Ezetimibe—Abdominal pain—Betamethasone—psoriatic arthritis	0.00029	0.00151	CcSEcCtD
Ezetimibe—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00029	0.00151	CcSEcCtD
Ezetimibe—Body temperature increased—Betamethasone—psoriatic arthritis	0.00029	0.00151	CcSEcCtD
Ezetimibe—Asthenia—Methylprednisolone—psoriatic arthritis	0.000289	0.00151	CcSEcCtD
Ezetimibe—Insomnia—Prednisone—psoriatic arthritis	0.000289	0.00151	CcSEcCtD
Ezetimibe—Paraesthesia—Prednisone—psoriatic arthritis	0.000287	0.0015	CcSEcCtD
Ezetimibe—Pruritus—Triamcinolone—psoriatic arthritis	0.000286	0.00149	CcSEcCtD
Ezetimibe—Cough—Methotrexate—psoriatic arthritis	0.000285	0.00149	CcSEcCtD
Ezetimibe—Pruritus—Methylprednisolone—psoriatic arthritis	0.000285	0.00149	CcSEcCtD
Ezetimibe—Dyspepsia—Prednisone—psoriatic arthritis	0.000281	0.00147	CcSEcCtD
Ezetimibe—Myalgia—Methotrexate—psoriatic arthritis	0.000279	0.00145	CcSEcCtD
Ezetimibe—Arthralgia—Methotrexate—psoriatic arthritis	0.000279	0.00145	CcSEcCtD
Ezetimibe—Chest pain—Methotrexate—psoriatic arthritis	0.000279	0.00145	CcSEcCtD
Ezetimibe—Decreased appetite—Prednisone—psoriatic arthritis	0.000278	0.00145	CcSEcCtD
Ezetimibe—Rash—Prednisolone—psoriatic arthritis	0.000277	0.00145	CcSEcCtD
Ezetimibe—Dermatitis—Prednisolone—psoriatic arthritis	0.000277	0.00145	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000277	0.00144	CcSEcCtD
Ezetimibe—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000276	0.00144	CcSEcCtD
Ezetimibe—Fatigue—Prednisone—psoriatic arthritis	0.000275	0.00144	CcSEcCtD
Ezetimibe—Headache—Prednisolone—psoriatic arthritis	0.000275	0.00144	CcSEcCtD
Ezetimibe—Discomfort—Methotrexate—psoriatic arthritis	0.000275	0.00144	CcSEcCtD
Ezetimibe—Constipation—Prednisone—psoriatic arthritis	0.000273	0.00143	CcSEcCtD
Ezetimibe—Confusional state—Methotrexate—psoriatic arthritis	0.000269	0.00141	CcSEcCtD
Ezetimibe—Dizziness—Triamcinolone—psoriatic arthritis	0.000267	0.0014	CcSEcCtD
Ezetimibe—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000267	0.00139	CcSEcCtD
Ezetimibe—Dizziness—Methylprednisolone—psoriatic arthritis	0.000267	0.00139	CcSEcCtD
Ezetimibe—Infection—Methotrexate—psoriatic arthritis	0.000265	0.00139	CcSEcCtD
Ezetimibe—Feeling abnormal—Prednisone—psoriatic arthritis	0.000263	0.00137	CcSEcCtD
Ezetimibe—Asthenia—Betamethasone—psoriatic arthritis	0.000263	0.00137	CcSEcCtD
Ezetimibe—Asthenia—Dexamethasone—psoriatic arthritis	0.000263	0.00137	CcSEcCtD
Ezetimibe—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000262	0.00137	CcSEcCtD
Ezetimibe—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000261	0.00137	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000261	0.00136	CcSEcCtD
Ezetimibe—Nausea—Prednisolone—psoriatic arthritis	0.000261	0.00136	CcSEcCtD
Ezetimibe—Pruritus—Dexamethasone—psoriatic arthritis	0.00026	0.00136	CcSEcCtD
Ezetimibe—Pruritus—Betamethasone—psoriatic arthritis	0.00026	0.00136	CcSEcCtD
Ezetimibe—Skin disorder—Methotrexate—psoriatic arthritis	0.000259	0.00135	CcSEcCtD
Ezetimibe—Vomiting—Triamcinolone—psoriatic arthritis	0.000257	0.00134	CcSEcCtD
Ezetimibe—Vomiting—Methylprednisolone—psoriatic arthritis	0.000256	0.00134	CcSEcCtD
Ezetimibe—Rash—Triamcinolone—psoriatic arthritis	0.000255	0.00133	CcSEcCtD
Ezetimibe—Dermatitis—Triamcinolone—psoriatic arthritis	0.000255	0.00133	CcSEcCtD
Ezetimibe—Rash—Methylprednisolone—psoriatic arthritis	0.000254	0.00133	CcSEcCtD
Ezetimibe—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000254	0.00133	CcSEcCtD
Ezetimibe—Urticaria—Prednisone—psoriatic arthritis	0.000254	0.00133	CcSEcCtD
Ezetimibe—Headache—Triamcinolone—psoriatic arthritis	0.000253	0.00132	CcSEcCtD
Ezetimibe—Headache—Methylprednisolone—psoriatic arthritis	0.000253	0.00132	CcSEcCtD
Ezetimibe—Abdominal pain—Prednisone—psoriatic arthritis	0.000253	0.00132	CcSEcCtD
Ezetimibe—Body temperature increased—Prednisone—psoriatic arthritis	0.000253	0.00132	CcSEcCtD
Ezetimibe—Diarrhoea—Betamethasone—psoriatic arthritis	0.000251	0.00131	CcSEcCtD
Ezetimibe—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000251	0.00131	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000243	0.00127	CcSEcCtD
Ezetimibe—Dizziness—Dexamethasone—psoriatic arthritis	0.000243	0.00127	CcSEcCtD
Ezetimibe—Dizziness—Betamethasone—psoriatic arthritis	0.000243	0.00127	CcSEcCtD
Ezetimibe—Insomnia—Methotrexate—psoriatic arthritis	0.000241	0.00126	CcSEcCtD
Ezetimibe—Nausea—Triamcinolone—psoriatic arthritis	0.00024	0.00125	CcSEcCtD
Ezetimibe—Paraesthesia—Methotrexate—psoriatic arthritis	0.00024	0.00125	CcSEcCtD
Ezetimibe—Nausea—Methylprednisolone—psoriatic arthritis	0.00024	0.00125	CcSEcCtD
Ezetimibe—Dyspnoea—Methotrexate—psoriatic arthritis	0.000238	0.00124	CcSEcCtD
Ezetimibe—Hypersensitivity—Prednisone—psoriatic arthritis	0.000235	0.00123	CcSEcCtD
Ezetimibe—Dyspepsia—Methotrexate—psoriatic arthritis	0.000235	0.00123	CcSEcCtD
Ezetimibe—Vomiting—Betamethasone—psoriatic arthritis	0.000233	0.00122	CcSEcCtD
Ezetimibe—Vomiting—Dexamethasone—psoriatic arthritis	0.000233	0.00122	CcSEcCtD
Ezetimibe—Decreased appetite—Methotrexate—psoriatic arthritis	0.000232	0.00121	CcSEcCtD
Ezetimibe—Rash—Betamethasone—psoriatic arthritis	0.000231	0.00121	CcSEcCtD
Ezetimibe—Rash—Dexamethasone—psoriatic arthritis	0.000231	0.00121	CcSEcCtD
Ezetimibe—Dermatitis—Betamethasone—psoriatic arthritis	0.000231	0.00121	CcSEcCtD
Ezetimibe—Dermatitis—Dexamethasone—psoriatic arthritis	0.000231	0.00121	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000231	0.0012	CcSEcCtD
Ezetimibe—Fatigue—Methotrexate—psoriatic arthritis	0.00023	0.0012	CcSEcCtD
Ezetimibe—Headache—Dexamethasone—psoriatic arthritis	0.00023	0.0012	CcSEcCtD
Ezetimibe—Headache—Betamethasone—psoriatic arthritis	0.00023	0.0012	CcSEcCtD
Ezetimibe—Asthenia—Prednisone—psoriatic arthritis	0.000229	0.0012	CcSEcCtD
Ezetimibe—Pain—Methotrexate—psoriatic arthritis	0.000228	0.00119	CcSEcCtD
Ezetimibe—Pruritus—Prednisone—psoriatic arthritis	0.000226	0.00118	CcSEcCtD
Ezetimibe—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00022	0.00115	CcSEcCtD
Ezetimibe—Diarrhoea—Prednisone—psoriatic arthritis	0.000219	0.00114	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000218	0.00114	CcSEcCtD
Ezetimibe—Nausea—Betamethasone—psoriatic arthritis	0.000218	0.00114	CcSEcCtD
Ezetimibe—Nausea—Dexamethasone—psoriatic arthritis	0.000218	0.00114	CcSEcCtD
Ezetimibe—Urticaria—Methotrexate—psoriatic arthritis	0.000212	0.00111	CcSEcCtD
Ezetimibe—Dizziness—Prednisone—psoriatic arthritis	0.000211	0.0011	CcSEcCtD
Ezetimibe—Abdominal pain—Methotrexate—psoriatic arthritis	0.000211	0.0011	CcSEcCtD
Ezetimibe—Body temperature increased—Methotrexate—psoriatic arthritis	0.000211	0.0011	CcSEcCtD
Ezetimibe—Vomiting—Prednisone—psoriatic arthritis	0.000203	0.00106	CcSEcCtD
Ezetimibe—Rash—Prednisone—psoriatic arthritis	0.000201	0.00105	CcSEcCtD
Ezetimibe—Dermatitis—Prednisone—psoriatic arthritis	0.000201	0.00105	CcSEcCtD
Ezetimibe—Headache—Prednisone—psoriatic arthritis	0.0002	0.00105	CcSEcCtD
Ezetimibe—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000197	0.00103	CcSEcCtD
Ezetimibe—Asthenia—Methotrexate—psoriatic arthritis	0.000192	0.001	CcSEcCtD
Ezetimibe—Nausea—Prednisone—psoriatic arthritis	0.00019	0.000991	CcSEcCtD
Ezetimibe—Pruritus—Methotrexate—psoriatic arthritis	0.000189	0.000987	CcSEcCtD
Ezetimibe—Diarrhoea—Methotrexate—psoriatic arthritis	0.000183	0.000954	CcSEcCtD
Ezetimibe—Dizziness—Methotrexate—psoriatic arthritis	0.000177	0.000922	CcSEcCtD
Ezetimibe—Vomiting—Methotrexate—psoriatic arthritis	0.00017	0.000887	CcSEcCtD
Ezetimibe—Rash—Methotrexate—psoriatic arthritis	0.000168	0.000879	CcSEcCtD
Ezetimibe—Dermatitis—Methotrexate—psoriatic arthritis	0.000168	0.000878	CcSEcCtD
Ezetimibe—Headache—Methotrexate—psoriatic arthritis	0.000167	0.000874	CcSEcCtD
Ezetimibe—Nausea—Methotrexate—psoriatic arthritis	0.000159	0.000828	CcSEcCtD
